
Novartis India reported a 13.8 percent year-on-year decline in net profit to approximately Rs 25.3 crore for Q4 FY26, despite a 7.9 percent rise in revenue to Rs 90.5 crore. Earnings per share fell to Rs 10.23 from Rs 11.87 in the previous year. The company saw a sequential profit increase of 56.9 percent from the prior quarter, supported by improved operations and lower tax impact. For FY26, revenue rose 5.3 percent to Rs 354.2 crore, while annual net profit declined 7.6 percent to Rs 93.2 crore.
The articles present financial data without political framing, focusing on Novartis India's quarterly and annual performance. Both sources provide factual reporting on revenue, profit, and earnings per share, without political commentary or partisan perspectives, reflecting a neutral business news approach.
The overall tone is neutral to slightly negative, emphasizing the decline in net profit and earnings per share despite revenue growth. The coverage highlights both positive aspects, such as increased sales and sequential profit recovery, and challenges like elevated expenses and annual profit decline, resulting in a balanced but cautious sentiment.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| moneycontrol | Novartis India Standalone March 2026 Net Sales at Rs 90.55 crore, up 7.95 Y-o-Y- Moneycontrol.com | Center | Neutral |
| freepressjournal | Novartis India Q4 Profit Slips 14 To 25 Crore Despite Higher Revenue | Center | Neutral |
freepressjournal broke this story on 12 May, 10:05 am. Other outlets followed.
Well-covered story — coverage matches public importance.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.